Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- To Aggressively Increase Deals with Top 10 Makers: Mr Bessho of Suzuken
June 21, 2004
- PRESS SEMINAR
June 21, 2004
- Ethical Drug Market Grows 3.6% to \7.97 Trillion in FY2003: IMS Japan
June 21, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 21, 2004
- Sumitomo to Beef Up Promotional Efforts for Lullan
June 21, 2004
- Renal Function Improved by Concomitant ACEI, ARB:JSN Meeting
June 21, 2004
- Teijin Pharma Looking for M&A Opportunity: Mr Ohyagi
June 21, 2004
- Diabetics Taking Lipitor Show Major Decreases in Heart Attacks, Strokes: ADA Meeting
June 21, 2004
- WEBSITE NEWS
June 21, 2004
- Genes to Predict Paclitaxel Effects Discoverd
June 21, 2004
- Wholesalers May Tie Up with Non-wholesalers: Mr Kimura of CR&C
June 21, 2004
- Uracil + Tegafur Improve Postoperative Survival in Rectal Cancer Patients: ASCO
June 21, 2004
- BUSINESS NEWS IN BRIEF -1-
June 21, 2004
- Tokushukai Group Plans Clinical Trials via Its Network
June 21, 2004
- BUSINESS NEWS IN BRIEF -2-
June 21, 2004
- Large-scale Study Started on Antihypertensive Combination Therapy: Jikei Univ. Group
June 21, 2004
- 5 NCEs Including Octreotide to Be Included in NHI List
June 21, 2004
- Large-Scale Study on Mosapride in Functional Dyspepsia Starts
June 21, 2004
- Chuikyo Members Call For Revision of Drug Pricing Rules
June 21, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
June 21, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…